IDEMIA launches Case AFIS, the Most Powerful Latent Examination Application on the Market

IDEMIA Case AFIS revolutionizes latent print examiners comparison speed, accuracy and operational quality excellence

Laptop IDEMIA Case AFISIDEMIA, the global leader in Augmented Identity, today announced the launch of IDEMIA Case AFIS, a sophisticated latent examination system empowered by our world-class biometric identification technology. Specially tailored for latent print examiners, IDEMIA Case AFIS is the only system backed by the latent matching capabilities supplied for over 160 national, state and local law enforcement agencies including the FBI’s Next Generation Identification (NGI) system.

IDEMIA is well known for its large scale and high performance AFIS with top rated accuracy for the last 43 years. Case AFIS brings the power of the large system to the convenience of a laptop. The application helps latent experts solve complex and difficult cases faster, by enabling examiners to search friction ridge evidence collected from crime scenes against known prints on a case by case basis. Case AFIS reduces erroneous examination decisions and provides better management of expert resources.

Donnie Scott

Through working with forensic experts on leading edge techniques and approaches, IDEMIA’s latent print examination discipline has resulted in our latest compact and convenient offering, IDEMIA Case AFIS. The power of our market leading MBIS (Multi Biometric Identification System) coupled with our advanced latent examination tools packaged in a portable form provide latent examiners with the best in crime-solving solutions.
Donnie Scott, Senior Vice President, Public Security for North America at IDEMIA

IDEMIA Case AFIS is a standalone system with powerful matching algorithms, independently tested for accuracy, speed and scalability. The solution empowers examiner performance in terms of speed, quality, consistency and efficiency. It also automates a manual comparison process without restrictions on record formats.

  • Accuracy – Case AFIS offers superior matching algorithms that increase system accuracy. IDEMIA employs top performing latent algorithms for both finger & palm.
  • Time savings for examiners – The powerful tools included in our Case AFIS application have proven effective in reducing and mostly eliminating backlog.
  • Reduce errors – Reduced erroneous exclusion and missed identification opportunities.

Demonstrations of Case AFIS will be given at IDEMIA’s booth at the 103rd Annual IAI International Forensic Educational Conference July 30 through August 1. A collaboration study by Elite Forensic Services using IDEMIA Case AFIS will also be presented as part of the educational conference agenda.

  • About IDEMIA - OT-Morpho is now IDEMIA, the global leader in Augmented Identity for an increasingly digital world, with the ambition to empower citizens and consumers alike to interact, pay, connect, travel and vote in ways that are now possible in a connected environment.

    Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, we reinvent the way we think, produce, use and protect this asset, whether for individuals or for objects. We ensure privacy and trust as well as guarantee secure, authenticated and verifiable transactions for international clients from Financial, Telecom, Identity, Public Security and IoT sectors.
    OT (Oberthur Technologies) and Safran Identity & Security (Morpho) have joined forces to form IDEMIA. With close to $3 billion in revenues and 14,000 employees around the world, IDEMIA serves clients in 180 countries.

    For more information, visit / Follow @IdemiaGroup on Twitter

your press contact(s).

Subscribe to our newsletter

Receive our key news and keep up with the trends in our markets by subscribing to our newsletter.

By clicking on the "Subscribe" button, you confirm that you agree to IDEMIA’s Terms of Use and Privacy Policy, and agree to the processing of your personal data and acknowledge your related rights, as described therein.

Your email address will be used exclusively by IDEMIA to send you newsletters related yo your selected topics of interest. In accordance with the law, you have rights of access, rectification and erasure of your personal data, as well as opposition of processing, which can be exercised by writing to